Sharechat Logo

Green Cross Health Limited 2022 Annual Report / NOM

Monday 27th June 2022

Text too small?

Notice is hereby given that the 2022 Annual Meeting of Shareholders of Green Cross Health Limited (“the Company”) will be held at the Ellerslie Event Centre 80 Ascot Avenue Greenlane Auckland on Monday, 25th of July 2022 at 2.30 pm.




A. Chair’s Address

B. Group Chief Executive Officer’s Address

C. Audited Financial Statements

D. Resolutions To consider and, if thought fit, to pass the following ordinary resolutions:


1. That Craig Brockliss be elected as a Director of the Company

2. That John Bolland be re-elected as a Director of the Company

3. That Kim Ellis be re-elected as a Director of the Company

4. To authorise the Directors to fix the remuneration of the Auditor for the ensuing year.


E. To consider any other matters that may be properly brought before the Annual Meeting.


Proxies and voting


Any shareholder who is entitled to attend and vote at the meeting may instead appoint a proxy to attend and vote on their behalf. The Chair of the Company is willing to act as proxy for any shareholder who may wish to appoint him for that purpose. The Chair intends to vote any undirected proxies in favour of the resolutions.


If you wish to appoint a proxy please complete the enclosed proxy form and mail to:


Computershare Investor Services limited

Private Bag 92119

Auckland 1142


Alternatively, you can complete a proxy form online at You will need the Control Number (found on the Proxy Notice), your CSN/security holder number and postcode or country of residence to vote online.


In either case, for your vote to be effective, your proxy must be received not less than 48 hours before the time of holding the meeting.


Note Biographical information relating to the Directors standing for election and re-election at the meeting can be found below.


Afternoon tea will be served at the conclusion of the meeting.


For and on behalf of the Board


Benjamin Doshi

Group Chief Financial Officer/Company Secretary

Dated: 27 June 2022


Craig Brockliss

Non-Executive Director


Craig Brockliss is currently CEO of the Wilton Capital Group of companies and has more than 20 years’ experience in business, property and private equity investing. Wilton has significant investment interests in New Zealand, the United States and in the UK.


Wilton Capital has its origins in the pharmaceutical logistics markets in New Zealand and Australia before diversifying into other investments in 2001.


Wilton is currently the third largest shareholder in Green Cross Health.


Craig holds a Bachelor of Commerce and a Bachelor of Laws from the University of Auckland and worked for Ernst and Young prior to joining the Wilton Group in 2001.


John Bolland

Non-Executive Director


John Bolland has more than 25 years experience in private equity, senior management and corporate finance. This includes 14 years with Ernst & Young, where he had Partner level responsibility in Corporate Finance and Audit & Business Advisory. John holds a Bachelor of Commerce from the University of Auckland and is a Member of the New Zealand Institute of Chartered Accountants. John is also a Director of PowerShield Limited.


John was appointed as a Non-Executive Director of the Company in August 2009.


Kim Ellis



During his business career Kim had wide Chief Executive experience and was best known for his 13 years at the helm of Waste Management NZ Ltd, culminating in the company’s sale in 2006. During his tenure he led 40 acquisitions and built a successful business in Australia.


Earlier roles encompassed a number of market sectors including health, manufacturing, distribution, transport, property, agriculture and fashion. Since 2006 Kim has been active in governance and is currently Chair of NZ Social Infrastructure Fund; a Director of Port of Tauranga and FSF Management Company; and consultant to Envirowaste Services.


Kim holds first class honours degrees in Chemical Engineering and Economics.

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Deferral of FDA consideration of enforcement discretion
MHJ - Response to ASX Query
CDI 2022 Interim Results
August 10th Morning Report
TWL - Resignation of Chief Operating Officer
NZA - Funding arrangements following Board changes
August 9th Morning Report
August 8th Morning Report
BIF - Potential material valuation increase for the fund
Nominations open for Fonterra Board of Directors' Election